Cargando…
Inhibitors of VPS34 and lipid metabolism suppress SARS-CoV-2 replication
Therapeutics targeting replication of SARS coronavirus 2 (SARS-CoV-2) are urgently needed. Coronaviruses rely on host membranes for entry, establishment of replication centers and egress. Compounds targeting cellular membrane biology and lipid biosynthetic pathways have previously shown promise as a...
Autores principales: | Silvas, Jesus A., Jureka, Alexander S., Nicolini, Anthony M., Chvatal, Stacie A., Basler, Christopher F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386504/ https://www.ncbi.nlm.nih.gov/pubmed/32743584 http://dx.doi.org/10.1101/2020.07.18.210211 |
Ejemplares similares
-
Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication
por: Williams, Caroline G., et al.
Publicado: (2021) -
Propagation, Inactivation, and Safety Testing of SARS-CoV-2
por: Jureka, Alexander S., et al.
Publicado: (2020) -
Aurone derivatives as Vps34 inhibitors that modulate autophagy
por: Li, Guodong, et al.
Publicado: (2019) -
Pulsed Broad-Spectrum UV Light Effectively Inactivates SARS-CoV-2 on Multiple Surfaces and N95 Material
por: Jureka, Alexander S., et al.
Publicado: (2021) -
Ubiquitination of the PI3-kinase VPS-34 promotes VPS-34 stability and phagosome maturation
por: Liu, Jinchao, et al.
Publicado: (2018)